FDA permits Zyn nicotine pouches to be marketed as safer than cigarettes

The U.S. Food and Drug Administration announced that Zyn's nicotine pouches can be advertised as a safer alternative to traditional cigarettes. The decision reflects the agency's view that the pouches expose users to fewer harmful smoke constituents than combustible tobacco products.

While the FDA allows the reduced‑risk claim, it notes that the products still deliver nicotine and are not risk‑free. The ruling is expected to shape how Zyn and similar smokeless tobacco brands position themselves in the market.

The article also mentions other health‑policy topics, including the influence of the alcohol industry on public policy and new AI tools for scientists, but the primary focus is the regulatory clearance for Zyn's marketing claim.